AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
Best Practice Webinar – Idiopathic Hypersomnia
Marketing Insights Best Practices | Idiopathic Hypersomnia | January 23, 2023
Join AMCP for an engaging webinar exploring key considerations in the management and diagnosis of idiopathic hypersomnia (IH). Affecting an estimated 20% of Americans, excessive daytime sleepiness (EDS) results in a substantially elevated risk of motor vehicle and work-related incidents, and individuals suffering from EDS have generally poorer overall health and higher health care resource utilization than comparable adults. Although the etiology of EDS may be multifactorial, central disorders of hypersomnolence—namely, narcolepsy and idiopathic hypersomnia (IH)—represent a direct underlying cause. IH is similar in presentation to narcolepsy, but diagnostic criteria are less definitive. As a result, IH can be difficult to distinguish from narcolepsy.
This session will feature a clinical key opinion leader and payer participants from the roundtable convened by AMCP in November 2024. The presenters will delve into the challenges of distinguishing IH from other sleep disorders, highlight advancements in diagnostic tools, and discuss evolving treatment strategies. Attendees will gain valuable insights into the broader impacts of IH on health outcomes and healthcare systems, with perspectives from clinical and payer experts.
Related
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
View our webinar on Managed Care Approaches to Address Unmet Patient Needs in Multiple Sclerosis (MS), a disease affecting nearly 1 million people in the U.S. Despite advancements in treatment, significant gaps remain in access, affordability, and comprehensive care.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
